Launch Your Drug in Southeast Asia with the Right Partners from Day One
We provide strategic market-entry consulting and connect you with the right distributor and channel partners for compliant, efficient launches across SEA.
Southeast Asia’s pharmaceutical market is growing rapidly, fueled by rising patient demand, evolving regulations, and investment in innovative therapies. Valued at over $40 billion (Source of Asia, 2023), SEA offers significant opportunities and challenges for strategic market entry and expansion.
Who We Are
At E & H Meta Resources, we guide you through agile, tailored market-entry planning for Southeast Asia - strategically identifying distributor partners whose expertise matches your therapeutic focus and access goals.
Our team brings decades of hands-on, in-country experience in market access, commercial strategy, and regulatory affairs - specializing in key SEA markets such as Singapore, Malaysia, Vietnam, and Thailand. We ensure your expansion is seamless, compliant, and impactful.
Who We Are
At E & H Meta Resources, we guide you through agile, tailored market-entry planning for Southeast Asia - strategically identifying distributor partners whose expertise matches your therapeutic focus and access goals.
Our team brings decades of hands-on, in-country experience in market access, commercial strategy, and regulatory affairs - specializing in key SEA markets such as Singapore, Malaysia, Vietnam, and Thailand. We ensure your expansion is seamless, compliant, and impactful.
Complex regulations, fragmented markets, and finding the right partner can stall your SEA launch. We turn these obstacles into opportunities - with expert strategy, trusted local partners, and seamless onboarding.
Navigate Southeast Asia’s Pharma Market With Local Experts and Reliable Partners
Our end-to-end solutions connect insight, strategy, and local execution for seamless Southeast Asia market access and expansion.
Market assesstments & Strategy
Detailed opportunity analysis, entry model selection, and tailored go-to-market plans.
Partner & Channel Development
Outreach, introductions, and facilitation of agreements with aligned distributors and channel partners.
Regulatory & Commercial Enablement
Guidance on approvals, compliance documentation, and launch readiness.
How We Deliver Results
01.
Industry-Specific Intelligence
We apply deep sector knowledge and AI-powered analytics to uncover insights that reveal market opportunities and inform confident entry decisions.
02.
Regulatory Pathway Navigation
We apply in-depth knowledge of Southeast Asia’s healthcare policies and regulatory strategy to navigate complex approval pathways, cut through red tape, and ensure a smooth, compliant launch.
03.
Strategic Partner Identification
We pre-screen and recommend compliant, specialty-focused distributors in your target markets, ensuring alignment with your therapeutic area and commercial objectives.
Your Bridge to Southeast Asia’s Markets
We’re practitioners, not just consultants.
Our team has led successful product launches for small, mid, and large-cap pharma in oncology, rare diseases, and specialty medicines across SEA.
With proven expertise in commercial strategy, sales, marketing, medical affairs, and market access, we understand your real-world challenges firsthand.
Our solutions are targeted, compliance-driven, and fast, delivered through a trusted network of local partners.
What Our Clients Say
Pharmaceutical and biotech leaders trust us for actionable advice, reliable partnerships, and measurable results.
E&H provided practical, hands-on support that made all the difference in our Southeast Asia launch. Their understanding of local markets gave us insights we couldn't have gained alone, and their established relationships with local distributors opened the doors for us. This saved us months of searching for the right partners. I don't think we could have pulled off such a smooth expansion without their regional expertise.
— Ewan McDowall, Chairman at EW-CHANGE Ltd UK
What I appreciated most about working with them was that they truly understand pharma from the inside - their team has actually worked in our industry, not just consulted for it. They knew exactly what we needed without lengthy explanations and consistently met their commitments. Gathering market insights across multiple markets could have been quite challenging, but they kept everything organized and on track. We highly recommend E&H as a strategic partner for any organization seeking to make an impact in the market!
— Florence Sim, Operations Director, Instamed Asia
Having partnered with numerous firms throughout our extensive experience, we can confidently say that E&H stands out as a top-tier collaborator. When our priorities shifted mid-project due to competitive pressures, they pivoted quickly without missing a beat. They moved fast on critical market entry decisions - no endless meetings or delays. Their flexibility let us adjust as market conditions changed. It's exactly what you need in today's fast-moving pharma landscape.
— Jean-Francois Baladi, Managing Director, Market Access Advisory International LLC
Frequently Asked Questions
What does the engagement process look like?
We begin by aligning on your goals, then assess entry models and local regulatory requirements. We recommend the best-fit market entry options, tailored to local opportunities and supported by a clear, actionable assessment.
How do you select and vet your local distributor partners?
We pre-screen potential partners through background checks, market reputation reviews, compliance history, and therapeutic-area fit, connecting you only with those proven to be reliable, experienced, and aligned with your goals.
What does your support include before, during, and after entry?
We guide you through assessment, partner selection, and onboarding. Once your partners are ready, we step back so you can manage ongoing relationships independently—ensuring a smooth handover and empowering local success.